| Net loss | -125.2M |
| Depreciation | |
| Amortization | |
| Deferred income taxes, net of valuation allowance | -200K |
| Goodwill impairment | |
| Asset disposals | 0 |
| Inventory write-offs | 0 |
| Stock-based compensation | 800K |
| Pension settlement | |
| Other | 1.6M |
| Litigation settlement payment | |
| Accounts receivable | 18M |
| Inventories | 6.4M |
| Other assets | 5.6M |
| Accounts payable | -14.4M |
| Accrued payroll and other liabilities | -32.8M |
| Restricted cash | 500K |
| Net cash (used in) provided by operating activities | -84.8M |
| Capital expenditures | -800K |
| Acquisitions | 0 |
| License agreement payment | |
| Other, net | |
| Net cash used in investing activities | 25M |
| Purchase of treasury stock | -200K |
| Exercise of stock options | 0 |
| Net cash used in financing activities | -400K |
| Effect of exchange rate changes on cash and cash equivalents | -200K |
| Net change in cash and cash equivalents | -60.4M |
| Cash and cash equivalents — beginning of period | 70.4M |
| Cash and Cash Equivalents - end of period | 10M |